BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35280824)

  • 21. WIPI-dependent autophagy during neutrophil differentiation of NB4 acute promyelocytic leukemia cells.
    Brigger D; Proikas-Cezanne T; Tschan MP
    Cell Death Dis; 2014 Jul; 5(7):e1315. PubMed ID: 24991767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells.
    Takeshita A; Shinjo K; Naito K; Matsui H; Sahara N; Shigeno K; Horii T; Shirai N; Maekawa M; Ohnishi K; Naoe T; Ohno R
    Leukemia; 2005 Aug; 19(8):1306-11. PubMed ID: 15920495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
    Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
    Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
    Özpolat B
    Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.
    Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD
    Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells.
    Albanesi J; Noguera NI; Banella C; Colangelo T; De Marinis E; Leone S; Palumbo O; Voso MT; Ascenzi P; Nervi C; Bianchi F; di Masi A
    Cells; 2020 Nov; 9(11):. PubMed ID: 33167477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide inhibits ATRA-induced prostaglandin E2 and cyclooxygenase-1 in NB4 cells, a model of acute promyelocytic leukemia.
    Habib A; Hamade E; Mahfouz R; Nasrallah MS; de Thé H; Bazarbachi A
    Leukemia; 2008 Jun; 22(6):1125-30. PubMed ID: 18354491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
    Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
    Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
    Liu D; Zhong L; Yuan Z; Yao J; Zhong P; Liu J; Yao S; Zhao Y; Liu L; Chen M; Li L; Liu B
    Cell Signal; 2019 Feb; 54():1-9. PubMed ID: 30453015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
    Kang C; Kim CY; Kim HS; Park SP; Chung HM
    Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways.
    Wang LN; Tang YL; Zhang YC; Zhang ZH; Liu XJ; Ke ZY; Li Y; Tan HZ; Huang LB; Luo XQ
    Leuk Lymphoma; 2017 Oct; 58(10):2426-2438. PubMed ID: 28276286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid.
    Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takei M; Takeuchi J; Takagi N; Toyoda H
    Int J Oncol; 2014 Mar; 44(3):865-73. PubMed ID: 24379003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L; Zou Y; Chen Y; Guo Y; Yang W; Chen X; Wang S; Liu X; Ruan M; Zhang J; Liu T; Liu F; Qi B; An W; Ren Y; Chang L; Zhu X
    BMC Cancer; 2018 Apr; 18(1):374. PubMed ID: 29615003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic trioxide augments all-trans retinoic acid-induced differentiation of HL-60 cells.
    Sumi D; Suzukawa K; Himeno S
    Life Sci; 2016 Mar; 149():42-50. PubMed ID: 26892147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-
    Sunami Y; Araki M; Kan S; Ito A; Hironaka Y; Imai M; Morishita S; Ohsaka A; Komatsu N
    J Biol Chem; 2017 Feb; 292(7):2815-2829. PubMed ID: 28053092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells.
    Gu ZM; Wu YL; Zhou MY; Liu CX; Xu HZ; Yan H; Zhao Y; Huang Y; Sun HD; Chen GQ
    Blood; 2010 Dec; 116(24):5289-97. PubMed ID: 20739655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
    Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.